Matthew M. Heeney

Matthew M. Heeney, MD, is Associate Professor of Pediatrics at Harvard Medical School and Associate Chief of Hematology at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, where he directs the Sickle Cell Program.

Education:

• University of Toronto (BS, 1992)
• University of Calgary (MD, 1995)
• McGill University/Montreal Children's Hospital (Residency, 1999)
• Duke University Medical Center (Fellowship, 2002)

Research focuses on sickle cell disease therapeutics and inherited disorders of iron metabolism. Clinical investigations include hydroxyurea alternatives for stroke prevention, prasugrel/regadenoson trials, and genetic basis of iron homeostasis abnormalities. Translational work identifies therapeutic targets through high-throughput drug screening.

As Co-Director of Hematology education at HMS, develops curriculum on anemia pathophysiology and management. Leads multicenter clinical trials through NIH consortia including SWiTCH/TWiTCH studies.